Epion Therapeutics Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$18.5M
- Investors
-
3
Epion Therapeutics General Information
Description
Developer of a minimally invasive corneal cross-linking treatment designed to treat keratoconus and ectatic corneal diseases. The company offers an epithelium-preserving treatment system for patients with corneal disorders, enabling treatment without disrupting the corneal epithelium and allowing a quicker return to normal activities.
Contact Information
Website
www.epiontx.comCorporate Office
- 1500 District Avenue
- Burlington, MA 01803
- United States
Corporate Office
- 1500 District Avenue
- Burlington, MA 01803
- United States
Epion Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 12-Sep-2025 | $18.5M | Completed | Clinical Trials - Phase 3 | ||
| 1. Later Stage VC (Series A) | 30-Sep-2022 | Completed | Clinical Trials - Phase 3 |
Epion Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Epion Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Epion Therapeutics Patents
Epion Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3122296-A1 | Ophthalmic treatment solution delivery devices and delivery augmentation methods | Active | 12-May-2014 | ||
| EP-3122296-A4 | Ophthalmic treatment solution delivery devices and delivery augmentation methods | Active | 12-May-2014 | ||
| EP-3122296-B1 | Ophthalmic treatment solution delivery devices and delivery augmentation methods | Active | 12-May-2014 | ||
| EP-3406229-A1 | Ophthalmic treatment solution delivery devices and delivery augmentation methods | Active | 12-May-2014 | ||
| EP-3406229-B1 | Ophthalmic treatment solution delivery devices and delivery augmentation methods | Active | 12-May-2014 | A61F9/0008 |
Epion Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Epion Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| New World Angels | Angel Group | Minority | ||
| 7G Bioventures | Venture Capital | Minority | ||
| AXA Investment Managers | Asset Manager | Minority |
Epion Therapeutics FAQs
-
When was Epion Therapeutics founded?
Epion Therapeutics was founded in 2012.
-
Where is Epion Therapeutics headquartered?
Epion Therapeutics is headquartered in Burlington, MA.
-
What is the size of Epion Therapeutics?
Epion Therapeutics has 5 total employees.
-
What industry is Epion Therapeutics in?
Epion Therapeutics’s primary industry is Biotechnology.
-
Is Epion Therapeutics a private or public company?
Epion Therapeutics is a Private company.
-
What is Epion Therapeutics’s current revenue?
The current revenue for Epion Therapeutics is .
-
How much funding has Epion Therapeutics raised over time?
Epion Therapeutics has raised $50.5M.
-
Who are Epion Therapeutics’s investors?
New World Angels, 7G Bioventures, and AXA Investment Managers have invested in Epion Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
